WallStreetZen

NYSE: ASPN
Aspen Aerogels Inc Stock Forecast, Predictions & Price Target

Analyst price target for ASPN

Based on 4 analysts offering 12 month price targets for Aspen Aerogels Inc.
Min Forecast
$36.00-27.27%
Avg Forecast
$47.50-4.04%
Max Forecast
$58.00+17.17%

Should I buy or sell ASPN stock?

Based on 4 analysts offering ratings for Aspen Aerogels Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ASPN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Piper Sandler
Top 1%
100
Strong BuyInitiates Coverage On$58.00+17.17%2021-09-10
Oppenheimer
Top 6%
95
BuyInitiates Coverage On$51.00+3.03%2021-08-17
Anonymous
Canaccord Genuity
Strong BuyMaintains$45.00-9.09%2021-07-30
Canaccord Genuity
Top 8%
93
Strong BuyMaintains$36.00-27.27%2021-07-01
HC Wainwright & Co.
Top 8%
93
BuyUpgrades$45.00-9.09%2021-07-01

1 of 1

Forecast return on equity

Is ASPN forecast to generate an efficient return?
Company
10.3%
Industry
22.58%
Market
18.14%
ASPN's Return on Equity is forecast to be low in 3 years (10.3%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ASPN forecast to generate an efficient return on assets?
Company
7.88%
Industry
10.72%
ASPN is forecast to generate lower Return on Assets (7.88%) than the US Basic Materials industry average (10.72%)
Forecast

ASPN earnings per share forecast

What is ASPN's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$0.98+5.38%
Avg 2 year Forecast
-$0.72-22.58%
Avg 3 year Forecast
-$0.02-97.85%

ASPN revenue forecast

What is ASPN's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$116.2M+8.6%
Avg 2 year Forecast
$144.7M+35.3%
Avg 3 year Forecast
$225.9M+111.14%
ASPN's revenue is forecast to grow at an exceptional rate of 26.33% per year
Forecast

ASPN revenue growth forecast

How is ASPN forecast to perform vs Basic Materials companies and vs the US market?
Company
26.33%
Industry
5.4%
Market
11.92%
ASPN's revenues are forecast to grow faster (26.33% per year) than the US Basic Materials industry average (5.4%)
Forecast
ASPN's revenues are forecast to grow faster (26.33% per year) than the US market average (11.92%)
Forecast

Aspen Aerogels Stock Forecast FAQ

Is Aspen Aerogels Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: ASPN) stock is to Strong Buy ASPN stock.

Out of 4 analysts, 2 (50%) are recommending ASPN as a Strong Buy, 2 (50%) are recommending ASPN as a Buy, 0 (0%) are recommending ASPN as a Hold, 0 (0%) are recommending ASPN as a Sell, and 0 (0%) are recommending ASPN as a Strong Sell.

What is ASPN's earnings growth forecast for 2021-2023?

(NYSE: ASPN) Aspen Aerogels's forecast annual earnings growth rate of N/A is not forecast to beat the US Basic Materials industry's average forecast earnings growth rate of 19.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.51%.

Aspen Aerogels's earnings in 2021 is -$25,861,000.On average, 6 Wall Street analysts forecast ASPN's earnings for 2021 to be $-32,284,974, with the lowest ASPN earnings forecast at $-33,602,728, and the highest ASPN earnings forecast at $-31,296,658. On average, 6 Wall Street analysts forecast ASPN's earnings for 2022 to be $-23,719,573, with the lowest ASPN earnings forecast at $-27,013,958, and the highest ASPN earnings forecast at $-18,777,995.

In 2023, ASPN is forecast to generate $-658,877 in earnings, with the lowest earnings forecast at $-16,471,926 and the highest earnings forecast at $11,200,909.

What is ASPN's revenue growth forecast for 2021-2023?

(NYSE: ASPN) Aspen Aerogels's forecast annual revenue growth rate of 26.33% is forecast to beat the US Basic Materials industry's average forecast revenue growth rate of 5.4%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 11.92%.

Aspen Aerogels's revenue in 2021 is $106,980,000.On average, 6 Wall Street analysts forecast ASPN's revenue for 2021 to be $3,827,449,553, with the lowest ASPN revenue forecast at $3,724,961,233, and the highest ASPN revenue forecast at $3,881,312,749. On average, 6 Wall Street analysts forecast ASPN's revenue for 2022 to be $4,768,424,769, with the lowest ASPN revenue forecast at $4,515,778,376, and the highest ASPN revenue forecast at $5,049,962,920.

In 2023, ASPN is forecast to generate $7,441,324,120 in revenue, with the lowest revenue forecast at $7,141,238,581 and the highest revenue forecast at $7,755,904,953.

What is ASPN's forecast return on assets (ROA) for 2021-2024?

(NYSE: ASPN) forecast ROA is 7.88%, which is lower than the forecast US Basic Materials industry average of 10.72%.

What is ASPN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ASPN price target, the average ASPN price target is $47.50, with the highest ASPN stock price forecast at $58.00 and the lowest ASPN stock price forecast at $36.00.

On average, Wall Street analysts predict that Aspen Aerogels's share price could stay at $47.50 by Sep 10, 2022. The average Aspen Aerogels stock price prediction forecasts a potential downside of N/A from the current ASPN share price of $49.50.

What is ASPN's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ASPN) Aspen Aerogels's current Earnings Per Share (EPS) is -$0.93. On average, analysts forecast that ASPN's EPS will be $-0.98 for 2021, with the lowest EPS forecast at $-1.02, and the highest EPS forecast at $-0.95. On average, analysts forecast that ASPN's EPS will be $-0.72 for 2022, with the lowest EPS forecast at $-0.82, and the highest EPS forecast at $-0.57. In 2023, ASPN's EPS is forecast to hit $-0.02 (min: $-0.50, max: $0.34).

What is ASPN's forecast return on equity (ROE) for 2021-2024?

(NYSE: ASPN) forecast ROE is 10.3%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.